CD4 and neoplasm: To assess the mechanism of NARA1leukin’s anti-tumor effects, we analyzed the composition of tumor-infiltrating lymphocytes (TILs) with a particular interest in the ratio of CD8+ T to CD4+ Foxp3+ Treg cells.